耐火ITP的病原性:概述 耐火ITP的病原性
1Department of Pathology and Laboratory Medicine, Perelman-University of Pennsylvania School of Medicine, Philadelphia, Pennsylvania, USA.
British journal of haematology
|September 22, 2023
概括
耐火性免疫性血栓缩症 (ITP) 缺乏明确的诊断标准,使研究复杂化. 本综述探讨了潜在的耐火ITP潜在的生物学因素,指导未来的诊断和治疗策略.
科学领域:
- 血液学 血液学 血液学
- 免疫学 免疫学 免疫学
背景情况:
- 耐药性免疫血小板缺血症 (rITP) 影响不对标准治疗反应的患者,增加出血风险.
- 目前对rITP的定义各不相同,阻碍了研究和临床理解.
- 在rITP中,严重的ITP和明显的致病途径之间的区别仍然不清楚.
研究的目的:
- 审查与耐火性免疫血小板缺血症 (rITP) 相关的潜在生物特征.
- 探索可能区分rITP与典型免疫血小板缺血症 (ITP) 的差异.
- 为了确定预测或诊断rITP的潜在生物标志物.
主要方法:
- 关于研究免疫血小板缺血 (ITP) 的生物学因素的文献综述.
- 对遗传,表观遗传,免疫学和血小板相关因素的分析.
- 综合了与T细胞失调,自身抗体,补体激活和血小板动态相关的发现.
主要成果:
- 确定了与遗传/表观遗传因素,T细胞/细胞因子失调,抗体特征,补体激活和血小板产生/清除受损的潜在关联.
- 这些因素可能会导致免疫血小板衰竭 (ITP) 的耐火状态.
- 该审查强调了对耐火性疾病的定义和理解的异质性.
结论:
- 了解rITP中的特定致病途径至关重要.
- 需要使用新方法的纵向研究来识别和监测关键生物标志物.
- 这项研究旨在改善耐火性免疫血小板的诊断,监测和治疗.
相关概念视频
Formation of the Platelet Plug
6.6K
The platelet phase, the second stage of hemostasis, commences around 15-20 seconds after an injury. It follows and overlaps with the vascular phase, during which blood vessels constrict to minimize blood loss.
As the injured blood vessel contracts, endothelial cells undergo contraction, revealing collagen fibers in the basement membrane and underlying connective tissue. Furthermore, the plasma membrane of endothelial cells becomes adhesive, preparing the site for platelet adhesion. Platelets...
As the injured blood vessel contracts, endothelial cells undergo contraction, revealing collagen fibers in the basement membrane and underlying connective tissue. Furthermore, the plasma membrane of endothelial cells becomes adhesive, preparing the site for platelet adhesion. Platelets...
6.6K
Venous Thrombosis I: Introduction
12
Venous thrombosis, the most common disorder of the veins, involves the formation of a thrombus or blood clot associated with vein inflammation. It can be classified as either superficial vein thrombosis or deep vein thrombosis.Superficial Vein Thrombosis: This involves the formation of a thrombus in a superficial vein, usually the greater or lesser saphenous vein. Though less severe than deep vein thrombosis (DVT), SVT can lead to complications if untreated.Deep Vein Thrombosis (DVT): This...
12
Anticoagulant Drugs: Low-Molecular-Weight Heparins
741
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
741
Disorders of Hemostasis
982
Hemostasis, the process that stops bleeding after a blood vessel injury, is crucial for maintaining the integrity of the circulatory system. However, disorders of hemostasis can disrupt this delicate balance, leading to either excessive clotting or bleeding. These disorders can be broadly classified into thromboembolic disorders and bleeding disorders.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
982
Extrinsic and Intrinsic Pathways of Hemostasis
8.2K
Blood clotting or coagulation involves extrinsic and intrinsic pathways, which ultimately merge into the common pathway, forming a fibrin clot.
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which...
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which...
8.2K
Introduction to Hemostasis
8.2K
Hemostasis is a complex physiological process that prevents excessive bleeding when a blood vessel is injured. It's crucial for maintaining the integrity of the circulatory system, as it ensures that our blood remains fluid while still within the vascular network and yet clots to prevent blood loss upon vessel injury.
The three phases of hemostasis involve many clotting factors present in plasma and several substances released by platelets and injured tissue cells. It is a fast, localized,...
The three phases of hemostasis involve many clotting factors present in plasma and several substances released by platelets and injured tissue cells. It is a fast, localized,...
8.2K


